[Bronchiolitis (RS virus infection)].
Yamazaki
Tsutomu
T
Department of Infectious Diseases and Infection Control (Pediatrics), Saitama Medical School.
D000280:Administration, Inhalation; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000956:Antigens, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000008:administration & dosage; D001990:Bronchiolitis, Viral / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy / Q000821:virology; D003937:Diagnosis, Differential; D006801:Humans; D007273:Injections, Intramuscular; D000069455:Palivizumab; D011379:Prognosis; D011933:Reagent Kits, Diagnostic; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy / Q000821:virology; D012136:Respiratory Syncytial Viruses / Q000276:immunology / Q000302:isolation & purification; D012254:Ribavirin / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000956:Antigens, Viral; D000998:Antiviral Agents; D011933:Reagent Kits, Diagnostic; D012254:Ribavirin; D000069455:Palivizumab